These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthetic sorbents for removal of factor VIII inhibitors from haemophilic A plasma. Dahri L; Boisson-Vidal C; Regnault V; Muller D; Sultan Y; Stolz JF J Chromatogr B Biomed Appl; 1995 Feb; 664(1):47-54. PubMed ID: 7757240 [TBL] [Abstract][Full Text] [Related]
3. Affinity of human anti-factor VIII antibodies for functional polystyrene supports. Dahri L; Stoltz JF; Boisson-Vidal C; Muller D; Jozefonvicz J J Mol Recognit; 1996; 9(5-6):401-6. PubMed ID: 9174917 [TBL] [Abstract][Full Text] [Related]
4. Polystyrene derivatives as candidates for extracorporeal adsorption of Factor VIII antibodies in the management of haemophiliac patients. Boisson-Vidal C; Haouam M; Lakhiari H; Huguet H; Dahri L; Sultan Y; Jozefonvicz J; Siali R Vox Sang; 2002 Oct; 83(3):214-21. PubMed ID: 12366762 [TBL] [Abstract][Full Text] [Related]
5. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains. Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535 [TBL] [Abstract][Full Text] [Related]
6. Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies. Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J J Biomater Sci Polym Ed; 1994; 6(8):695-705. PubMed ID: 7703186 [TBL] [Abstract][Full Text] [Related]
7. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors. Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537 [TBL] [Abstract][Full Text] [Related]
9. Anti-factor VIII antibodies: a 2005 update. Lavigne-Lissalde G; Schved JF; Granier C; Villard S Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627 [TBL] [Abstract][Full Text] [Related]
10. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors. Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406 [TBL] [Abstract][Full Text] [Related]
11. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients. Blanco AN; Peirano AA; Grosso SH; Gennari LC; Bianco RP; Lazzari MA Haematologica; 2000 Oct; 85(10):1045-50. PubMed ID: 11025595 [TBL] [Abstract][Full Text] [Related]
12. Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX. Knöbl P; Derfler K Vox Sang; 1999; 77 Suppl 1():57-64. PubMed ID: 10529691 [TBL] [Abstract][Full Text] [Related]
13. Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Lacroix-Desmazes S; Moreau A; Sooryanarayana ; Bonnemain C; Stieltjes N; Pashov A; Sultan Y; Hoebeke J; Kazatchkine MD; Kaveri SV Nat Med; 1999 Sep; 5(9):1044-7. PubMed ID: 10470082 [TBL] [Abstract][Full Text] [Related]
14. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains. Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780 [TBL] [Abstract][Full Text] [Related]
15. Factor VIII inhibitor with catalytic activity towards factor VIII. Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Kazatchkine MD; Kaveri SV Haematologica; 2000 Oct; 85(10 Suppl):89-92. PubMed ID: 11187883 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. Gilles JG; Desqueper B; Lenk H; Vermylen J; Saint-Remy JM J Clin Invest; 1996 Mar; 97(6):1382-8. PubMed ID: 8617869 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous detection and epitope mapping of anti-factor VIII antibodies. Lavigne-Lissalde G; Tarrade C; Lapalud P; Chtourou S; Schved JF; Granier C; Villard-Saussine S Thromb Haemost; 2008 Jun; 99(6):1090-6. PubMed ID: 18521513 [TBL] [Abstract][Full Text] [Related]
18. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells. Kaveri SV; Dasgupta S; Andre S; Navarrete AM; Repessé Y; Wootla B; Lacroix-Desmazes S Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399 [TBL] [Abstract][Full Text] [Related]
19. Adsorption of immunoglobulin G and anti-factor VIII inhibitory antibody from haemophiliac plasma to derivatized polystyrenes. Cornelius RM; Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J; Brash JL Biomaterials; 1997 Mar; 18(5):429-36. PubMed ID: 9061184 [TBL] [Abstract][Full Text] [Related]